{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T15:48:55Z","timestamp":1791301735767,"version":"4.1.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T00:00:00Z","timestamp":1750464000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T00:00:00Z","timestamp":1750464000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"crossref","award":["22140903800"],"award-info":[{"award-number":["22140903800"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Funct Integr Genomics"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s10142-025-01642-w","type":"journal-article","created":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T22:57:37Z","timestamp":1750460257000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Comprehensive multi-omics analysis of nucleotide metabolism: elucidating the role and prognostic significance of UCK2 in bladder cancer"],"prefix":"10.1007","volume":"25","author":[{"given":"Yadong","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyou","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wentao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haotian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongqiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zezhi","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyu","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xudong","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,21]]},"reference":[{"issue":"16","key":"1642_CR1","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1038\/onc.2014.155","volume":"34","author":"Y Aye","year":"2015","unstructured":"Aye Y, Li M, Long MJC, Weiss RS (2015) Ribonucleotide reductase and cancer: biological mechanisms and targeted therapies. Oncogene 34(16):2011\u20132021","journal-title":"Oncogene"},{"issue":"6","key":"1642_CR2","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.ccell.2019.10.007","volume":"36","author":"D Boison","year":"2019","unstructured":"Boison D, Yegutkin GG (2019) Adenosine Metabolism: Emerging Concepts for Cancer Therapy. Cancer Cell 36(6):582\u2013596","journal-title":"Cancer Cell"},{"issue":"12","key":"1642_CR3","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/s41389-020-00287-7","volume":"9","author":"J Cai","year":"2020","unstructured":"Cai J, Sun X, Guo H, Qu X, Huang H, Yu C et al (2020) Non-metabolic role of UCK2 links EGFR-AKT pathway activation to metastasis enhancement in hepatocellular carcinoma. Oncogenesis 9(12):103","journal-title":"Oncogenesis"},{"key":"1642_CR4","doi-asserted-by":"crossref","unstructured":"Chandel NS. (2021) Nucleotide Metabolism. Cold Spring Harb Perspect Biol 13(7).","DOI":"10.1101\/cshperspect.a040592"},{"issue":"11","key":"1642_CR5","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1021\/ar0000509","volume":"35","author":"RI Christopherson","year":"2002","unstructured":"Christopherson RI, Lyons SD, Wilson PK (2002) Inhibitors of de novo nucleotide biosynthesis as drugs. Acc Chem Res 35(11):961\u2013971","journal-title":"Acc Chem Res"},{"key":"1642_CR6","doi-asserted-by":"crossref","first-page":"1295693","DOI":"10.3389\/fimmu.2024.1295693","volume":"15","author":"C Dong","year":"2024","unstructured":"Dong C, Guo Y, Yang Y, Ge X (2024) Comprehensive analysis of PSME3: from pan-cancer analysis to experimental validation. Front Immunol 15:1295693","journal-title":"Front Immunol"},{"key":"1642_CR7","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.canlet.2021.01.026","volume":"503","author":"MA Fawal","year":"2021","unstructured":"Fawal MA, Jungas T, Davy A (2021) Inhibition of DHFR targets the self-renewing potential of brain tumor initiating cells. Cancer Lett 503:129\u2013137","journal-title":"Cancer Lett"},{"key":"1642_CR8","doi-asserted-by":"crossref","first-page":"904887","DOI":"10.3389\/fonc.2022.904887","volume":"12","author":"Y Fu","year":"2022","unstructured":"Fu Y, Wei XD, Guo L, Wu K, Le J, Ma Y et al (2022) The Metabolic and Non-Metabolic Roles of UCK2 in Tumor Progression. Front Oncol 12:904887","journal-title":"Front Oncol"},{"key":"1642_CR9","first-page":"175883592211086","volume":"14","author":"Y Guo","year":"2022","unstructured":"Guo Y, Zheng Z, Zhang W, Mao S, Yang F, Li W et al (2022) Gender dimorphism in survival of patients with lymph node metastasis of bladder cancer. Ther Adv Med Oncol 14:17588359221108690","journal-title":"Ther Adv Med Oncol"},{"issue":"2","key":"1642_CR10","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/mc.23475","volume":"62","author":"Y Guo","year":"2023","unstructured":"Guo Y, Zheng Z, Mao S, Yang F, Wang R, Wang H et al (2023) Metabolic-associated signature and hub genes associated with immune microenvironment and prognosis in bladder cancer. Mol Carcinog 62(2):185\u2013199","journal-title":"Mol Carcinog"},{"issue":"1","key":"1642_CR11","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1007\/s10637-010-9535-y","volume":"30","author":"LA Hammond-Thelin","year":"2012","unstructured":"Hammond-Thelin LA, Thomas MB, Iwasaki M, Abbruzzese JL, Lassere Y, Meyers CA et al (2012) Phase I and pharmacokinetic study of 3\u2019-C-ethynylcytidine (TAS-106), an inhibitor of RNA polymerase I, II and III, in patients with advanced solid malignancies. Invest New Drugs 30(1):316\u2013326","journal-title":"Invest New Drugs"},{"key":"1642_CR12","unstructured":"Islam S, Zahid U, Cooke L, Lee YB, Kim DJ, Benaim E et al (2017) RX-3117, a Novel Nucleoside Analog Targeting UCK2 Is Active Alone and Synergistic with Ibrutinib and Bendamustine in ABC and DH\/DPDiffuse Large B-Cell Lymphoma. Blood 130(Supplement 1):5196-"},{"issue":"1","key":"1642_CR13","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41585-018-0105-y","volume":"16","author":"B Jordan","year":"2019","unstructured":"Jordan B, Meeks JJ (2019) T1 bladder cancer: current considerations for diagnosis and management. Nat Rev Urol 16(1):23\u201334","journal-title":"Nat Rev Urol"},{"issue":"6","key":"1642_CR14","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.cmet.2023.03.017","volume":"35","author":"Q Li","year":"2023","unstructured":"Li Q, Zhang L, Yang Q, Li M, Pan X, Xu J et al (2023) Thymidine kinase 1 drives hepatocellular carcinoma in enzyme-dependent and -independent manners. Cell Metab 35(6):912\u201327.e7","journal-title":"Cell Metab"},{"key":"1642_CR15","doi-asserted-by":"crossref","first-page":"983490","DOI":"10.3389\/fimmu.2022.983490","volume":"13","author":"C Liu","year":"2022","unstructured":"Liu C, Zhang W, Zhou X, Liu L (2022) IMPDH1, a prognostic biomarker and immunotherapy target that correlates with tumor immune microenvironment in pan-cancer and hepatocellular carcinoma. Front Immunol 13:983490","journal-title":"Front Immunol"},{"issue":"3","key":"1642_CR16","doi-asserted-by":"crossref","first-page":"897","DOI":"10.7150\/ijbs.81609","volume":"19","author":"Y Liu","year":"2023","unstructured":"Liu Y, Sun Y, Guo Y, Shi X, Chen X, Feng W et al (2023) An Overview: The Diversified Role of Mitochondria in Cancer Metabolism. Int J Biol Sci 19(3):897\u2013915","journal-title":"Int J Biol Sci"},{"issue":"1","key":"1642_CR17","doi-asserted-by":"crossref","first-page":"e0170233","DOI":"10.1371\/journal.pone.0170233","volume":"12","author":"I Malami","year":"2017","unstructured":"Malami I, Abdul AB, Abdullah R, Kassim NK, Rosli R, Yeap SK et al (2017) Crude Extracts, Flavokawain B and Alpinetin Compounds from the Rhizome of Alpinia mutica Induce Cell Death via UCK2 Enzyme Inhibition and in Turn Reduce 18S rRNA Biosynthesis in HT-29 Cells. PLoS ONE 12(1):e0170233","journal-title":"PLoS ONE"},{"issue":"11","key":"1642_CR18","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1042\/BCJ20210770","volume":"479","author":"EC Matchett","year":"2022","unstructured":"Matchett EC, Ambrose EC, Kornbluth J (2022) Characterization of uridine-cytidine kinase like-1 nucleoside kinase activity and its role in tumor growth. Biochem J 479(11):1149\u20131164","journal-title":"Biochem J"},{"issue":"5","key":"1642_CR19","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.eururo.2023.05.011","volume":"84","author":"JJ Meeks","year":"2023","unstructured":"Meeks JJ, Black PC, Galsky M, Grivas P, Hahn NM, Hussain SA et al (2023) Checkpoint Inhibitors in Urothelial Carcinoma\u2014Future Directions and Biomarker Selection. Eur Urol 84(5):473\u2013483","journal-title":"Eur Urol"},{"issue":"1","key":"1642_CR20","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s40170-020-00218-5","volume":"8","author":"T Mollick","year":"2020","unstructured":"Mollick T, La\u00edn S (2020) Modulating pyrimidine ribonucleotide levels for the treatment of cancer. Cancer & Metabolism 8(1):12","journal-title":"Cancer & Metabolism"},{"issue":"5","key":"1642_CR21","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/s41568-023-00557-7","volume":"23","author":"NJ Mullen","year":"2023","unstructured":"Mullen NJ, Singh PK (2023) Nucleotide metabolism: a pan-cancer metabolic dependency. Nat Rev Cancer 23(5):275\u2013294","journal-title":"Nat Rev Cancer"},{"key":"1642_CR22","doi-asserted-by":"crossref","unstructured":"Mullen NJ, Shukla SK, Thakur R, Kollala SS, Wang D, Chaika N et al (2024) DHODH inhibition enhances the efficacy of immune checkpoint blockade by increasing cancer cell antigen presentation. Elife 12","DOI":"10.7554\/eLife.87292.3"},{"issue":"10","key":"1642_CR23","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1124\/dmd.104.000737","volume":"32","author":"D Murata","year":"2004","unstructured":"Murata D, Endo Y, Obata T, Sakamoto K, Syouji Y, Kadohira M et al (2004) A crucial role of uridine\/cytidine kinase 2 in antitumor activity of 3\u2019-ethynyl nucleosides. Drug Metab Dispos 32(10):1178\u20131182","journal-title":"Drug Metab Dispos"},{"key":"1642_CR24","doi-asserted-by":"crossref","unstructured":"Naffouje R, Grover P, Yu H, Sendilnathan A, Wolfe K, Majd N et al (2019) Anti-Tumor Potential of IMP Dehydrogenase Inhibitors: A Century-Long Story. Cancers (Basel) 11(9)","DOI":"10.3390\/cancers11091346"},{"issue":"2","key":"1642_CR25","doi-asserted-by":"crossref","first-page":"315","DOI":"10.18388\/abp.2016_1421","volume":"64","author":"T Przyby\u0142a","year":"2017","unstructured":"Przyby\u0142a T, Sakowicz-Burkiewicz M, Maciejewska I, Bielarczyk H, Pawe\u0142czyk T (2017) Suppression of ID1 expression in colon cancer cells increases sensitivity to 5-fluorouracil. Acta Biochim Pol 64(2):315\u2013322","journal-title":"Acta Biochim Pol"},{"key":"1642_CR26","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.canlet.2019.11.013","volume":"470","author":"AD Robinson","year":"2020","unstructured":"Robinson AD, Eich ML, Varambally S (2020) Dysregulation of de novo nucleotide biosynthetic pathway enzymes in cancer and targeting opportunities. Cancer Lett 470:134\u2013140","journal-title":"Cancer Lett"},{"issue":"9","key":"1642_CR27","doi-asserted-by":"crossref","first-page":"e0162901","DOI":"10.1371\/journal.pone.0162901","volume":"11","author":"D Sarkisjan","year":"2016","unstructured":"Sarkisjan D, Julsing JR, Smid K, de Klerk D, van Kuilenburg AB, Meinsma R et al (2016) The Cytidine Analog Fluorocyclopentenylcytosine (RX-3117) Is Activated by Uridine-Cytidine Kinase 2. PLoS ONE 11(9):e0162901","journal-title":"PLoS ONE"},{"issue":"23","key":"1642_CR28","doi-asserted-by":"crossref","first-page":"14379","DOI":"10.1021\/acs.chemrev.6b00209","volume":"116","author":"J Shelton","year":"2016","unstructured":"Shelton J, Lu X, Hollenbaugh JA, Cho JH, Amblard F, Schinazi RF (2016) Metabolism, Biochemical Actions, and Chemical Synthesis of Anticancer Nucleosides, Nucleotides, and Base Analogs. Chem Rev 116(23):14379\u201314455","journal-title":"Chem Rev"},{"issue":"2","key":"1642_CR29","doi-asserted-by":"crossref","first-page":"132","DOI":"10.4048\/jbc.2017.20.2.132","volume":"20","author":"G Shen","year":"2017","unstructured":"Shen G, He P, Mao Y, Li P, Luh F, Ding G et al (2017) Overexpression of Uridine-Cytidine Kinase 2 Correlates with Breast Cancer Progression and Poor Prognosis. J Breast Cancer 20(2):132\u2013141","journal-title":"J Breast Cancer"},{"issue":"9","key":"1642_CR30","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.21037\/tcr-23-136","volume":"12","author":"ZZ Shi","year":"2023","unstructured":"Shi ZZ, Jin X, Li WT, Tao H, Song SJ, Fan ZW et al (2023) Dihydroorotate dehydrogenase promotes cell proliferation and suppresses cell death in esophageal squamous cell carcinoma and colorectal carcinoma. Transl Cancer Res 12(9):2294\u20132307","journal-title":"Transl Cancer Res"},{"issue":"7","key":"1642_CR31","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1111\/j.1349-7006.2002.tb01325.x","volume":"93","author":"Y Shimamoto","year":"2002","unstructured":"Shimamoto Y, Koizumi K, Okabe H, Kazuno H, Murakami Y, Nakagawa F et al (2002) Sensitivity of human cancer cells to the new anticancer ribo-nucleoside TAS-106 is correlated with expression of uridine-cytidine kinase 2. Jpn J Cancer Res 93(7):825\u2013833","journal-title":"Jpn J Cancer Res"},{"issue":"11","key":"1642_CR32","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1038\/s41418-019-0289-6","volume":"26","author":"A Siddiqui","year":"2019","unstructured":"Siddiqui A, Gollavilli PN, Schwab A, Vazakidou ME, Ersan PG, Ramakrishnan M et al (2019) Thymidylate synthase maintains the de-differentiated state of triple negative breast cancers. Cell Death Differ 26(11):2223\u20132236","journal-title":"Cell Death Differ"},{"issue":"1","key":"1642_CR33","first-page":"17","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A (2023) Cancer statistics, 2023. CA Cancer J Clin 73(1):17\u201348","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"1642_CR34","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A et al (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin 71(3):209\u2013249","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"1642_CR35","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.cell.2016.08.057","volume":"167","author":"DB Sykes","year":"2016","unstructured":"Sykes DB, Kfoury YS, Mercier FE, Wawer MJ, Law JM, Haynes MK et al (2016) Inhibition of Dihydroorotate Dehydrogenase Overcomes Differentiation Blockade in Acute Myeloid Leukemia. Cell 167(1):171\u201386.e15","journal-title":"Cell"},{"issue":"4","key":"1642_CR36","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.ccell.2018.03.012","volume":"33","author":"DS Thommen","year":"2018","unstructured":"Thommen DS, Schumacher TN (2018) T Cell Dysfunction in Cancer. Cancer Cell 33(4):547\u2013562","journal-title":"Cancer Cell"},{"issue":"4","key":"1642_CR37","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.immuni.2018.03.023","volume":"48","author":"V Thorsson","year":"2018","unstructured":"Thorsson V, Gibbs DL, Brown SD, Wolf D, Bortone DS, Ou Yang T-H et al (2018) The Immune Landscape of Cancer. Immunity 48(4):812\u201330.e14","journal-title":"Immunity"},{"issue":"2","key":"1642_CR38","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/s41568-020-00313-1","volume":"21","author":"L Tran","year":"2021","unstructured":"Tran L, Xiao J-F, Agarwal N, Duex JE, Theodorescu D (2021) Advances in bladder cancer biology and therapy. Nat Rev Cancer 21(2):104\u2013121","journal-title":"Nat Rev Cancer"},{"issue":"14","key":"1642_CR39","doi-asserted-by":"crossref","first-page":"3602","DOI":"10.1016\/j.cell.2024.05.011","volume":"187","author":"DH Tran","year":"2024","unstructured":"Tran DH, Kim D, Kesavan R, Brown H, Dey T, Soflaee MH et al (2024) De novo and salvage purine synthesis pathways across tissues and tumors. Cell 187(14):3602\u201318.e20","journal-title":"Cell"},{"key":"1642_CR40","doi-asserted-by":"crossref","unstructured":"van Kuilenburg ABP, Meinsma R (2016) The pivotal role of uridine-cytidine kinases in pyrimidine metabolism and activation of cytotoxic nucleoside analogues in neuroblastoma. Biochim et Biophys Acta (BBA) - Mol Basis Dis 1862(9):1504\u201312","DOI":"10.1016\/j.bbadis.2016.05.012"},{"key":"1642_CR41","doi-asserted-by":"crossref","unstructured":"Villa E, Ali ES, Sahu U, Ben-Sahra I (2019) Cancer Cells Tune the Signaling Pathways to Empower de Novo Synthesis of Nucleotides. Cancers (Basel) 11(5)","DOI":"10.3390\/cancers11050688"},{"key":"1642_CR42","doi-asserted-by":"crossref","first-page":"684961","DOI":"10.3389\/fonc.2021.684961","volume":"11","author":"W Wang","year":"2021","unstructured":"Wang W, Cui J, Ma H, Lu W, Huang J (2021) Targeting Pyrimidine Metabolism in the Era of Precision Cancer Medicine. Front Oncol 11:684961","journal-title":"Front Oncol"},{"issue":"6","key":"1642_CR43","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1085\/jgp.8.6.519","volume":"8","author":"O Warburg","year":"1927","unstructured":"Warburg O, Wind F, Negelein E (1927) THE METABOLISM OF TUMORS IN THE BODY. J Gen Physiol 8(6):519\u2013530","journal-title":"J Gen Physiol"},{"issue":"8","key":"1642_CR44","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/nri3862","volume":"15","author":"EJ Wherry","year":"2015","unstructured":"Wherry EJ, Kurachi M (2015) Molecular and cellular insights into T cell exhaustion. Nat Rev Immunol 15(8):486\u2013499","journal-title":"Nat Rev Immunol"},{"issue":"9","key":"1642_CR45","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1111\/cas.14125","volume":"110","author":"Y Wu","year":"2019","unstructured":"Wu Y, Jamal M, Xie T, Sun J, Song T, Yin Q et al (2019) Uridine-cytidine kinase 2 (UCK2): A potential diagnostic and prognostic biomarker for lung cancer. Cancer Sci 110(9):2734\u20132747","journal-title":"Cancer Sci"},{"issue":"14","key":"1642_CR46","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.21037\/atm-21-2906","volume":"9","author":"H Wu","year":"2021","unstructured":"Wu H, Xu H, Jia D, Li T, Xia L (2021) METTL3-induced UCK2 m(6)A hypermethylation promotes melanoma cancer cell metastasis via the WNT\/\u03b2-catenin pathway. Ann Transl Med 9(14):1155","journal-title":"Ann Transl Med"},{"issue":"1","key":"1642_CR47","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s11658-022-00403-y","volume":"27","author":"D Wu","year":"2022","unstructured":"Wu D, Zhang C, Liao G, Leng K, Dong B, Yu Y et al (2022a) Targeting uridine-cytidine kinase 2 induced cell cycle arrest through dual mechanism and could improve the immune response of hepatocellular carcinoma. Cell Mol Biol Lett 27(1):105","journal-title":"Cell Mol Biol Lett"},{"issue":"1","key":"1642_CR48","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s11658-022-00403-y","volume":"27","author":"D Wu","year":"2022","unstructured":"Wu D, Zhang C, Liao G, Leng K, Dong B, Yu Y et al (2022b) Targeting uridine\u2013cytidine kinase 2 induced cell cycle arrest through dual mechanism and could improve the immune response of hepatocellular carcinoma. Cell Mol Biol Lett 27(1):105","journal-title":"Cell Mol Biol Lett"},{"issue":"4","key":"1642_CR49","doi-asserted-by":"crossref","first-page":"837","DOI":"10.32604\/biocell.2023.026161","volume":"47","author":"WEI Xia","year":"2023","unstructured":"Xia WEI, Yang N, Feng X, Xin T, Jing Y, Li Y et al (2023) UCK2 promotes the proliferation, migration, and invasion of trophoblast cells in preeclampsia by activating the STAT3 pathway. Biocell 47(4):837\u2013847","journal-title":"Biocell"},{"issue":"2","key":"1642_CR50","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1007\/s10142-023-01117-w","volume":"23","author":"X Yang","year":"2023","unstructured":"Yang X, Zhang B (2023) A review on CRISPR\/Cas: a versatile tool for cancer screening, diagnosis, and clinic treatment. Funct Integr Genomics 23(2):182","journal-title":"Funct Integr Genomics"},{"issue":"2","key":"1642_CR51","doi-asserted-by":"crossref","first-page":"e70011","DOI":"10.1002\/imt2.70011","volume":"4","author":"B Ye","year":"2025","unstructured":"Ye B, Fan J, Xue L, Zhuang Y, Luo P, Jiang A et al (2025) iMLGAM: Integrated Machine Learning and Genetic Algorithm-driven Multiomics analysis for pan-cancer immunotherapy response prediction. Imeta 4(2):e70011","journal-title":"Imeta"},{"key":"1642_CR52","doi-asserted-by":"crossref","first-page":"6339","DOI":"10.2147\/CMAR.S182859","volume":"10","author":"Q Zhou","year":"2018","unstructured":"Zhou Q, Jiang H, Zhang J, Yu W, Zhou Z, Huang P et al (2018) Uridine-cytidine kinase 2 promotes metastasis of hepatocellular carcinoma cells via the Stat3 pathway. Cancer Manag Res 10:6339\u20136355","journal-title":"Cancer Manag Res"},{"issue":"1","key":"1642_CR53","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s40170-021-00250-z","volume":"9","author":"Y Zhou","year":"2021","unstructured":"Zhou Y, Tao L, Zhou X, Zuo Z, Gong J, Liu X et al (2021) DHODH and cancer: promising prospects to be explored. Cancer Metab 9(1):22","journal-title":"Cancer Metab"}],"container-title":["Functional & Integrative Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10142-025-01642-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10142-025-01642-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10142-025-01642-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T08:12:38Z","timestamp":1769155958000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10142-025-01642-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,21]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1642"],"URL":"https:\/\/doi.org\/10.1007\/s10142-025-01642-w","relation":{},"ISSN":["1438-793X","1438-7948"],"issn-type":[{"value":"1438-793X","type":"print"},{"value":"1438-7948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,21]]},"assertion":[{"value":"23 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study received approval from the Ethics Committee of the Shanghai Tenth People's Hospital (approval number: 2021KN108). Informed consent was obtained from all patients involved in the study. All methods were conducted in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Consent for publication is not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}},{"value":"Not applicable.\u00a0","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}],"article-number":"133"}}